Introduction
Mycobacterium tuberculosis (Mtb) infects one-third of the world's population and causes almost 1.3 million deaths per year [1] . Approximately 90% of infected persons have latent tuberculosis infection (LTBI), have protective immunity and remain well, but 10% develop primary tuberculosis (TB) soon after infection or reactivation TB many years later [2] . HIV infection markedly increases susceptibility to TB, and HIV-infected persons with LTBI have an 800-fold greater risk of developing active TB (www.cdc.gov/tb/). TB is the leading cause of death in HIV-infected persons and more than half a million co-infected people die annually (www.avert.org/tuberculosis.htm).
Mtb can proliferate and survive in macrophages and other cells, favoring establishment and progression of infection, as well as the capacity to persist and reactivate disease many years later [2] [3] [4] . Interaction of macrophages with specific ligands, facilitates uptake of Mtb, and triggers an intracellular signaling cascade in macrophages that induces production of cytokines and chemokines essential to arrest bacterial growth [5, 6] . Key macrophage receptors that sense mycobacterial antigens include toll-like receptors (TLRs), CD14 co-receptor, https://doi.org/10.1016/j.cyto.2018. 05.005 and C-type lectin receptors [7] . Stimulation of TLR-dependent pathways induces activation of NF-kB, with subsequent production of inflammatory cytokines and chemokines and increased expression of costimulatory molecules [8] . This in turn regulates antimicrobial mechanisms, such as induction of autophagy, and generation of nitric oxide (NO), reactive nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI) all of which play critical roles in the clearance of mycobacteria [9, 10] . TLR2 uses the intracellular myeloid differentiation factor (MyD88) to link receptor recognition with activation of IL-1R-associated kinase-4 (IRAK4), for translocation of NF-κB and gene transcription and production of inflammatory cytokines [11] [12] [13] . MyD88 signaling is essential in the control of Mtb infection, absence of which resulted in a dramatic reduction of host resistance to TB [14, 15] . IRAK4 acts immediately downstream of MyD88 and has been shown to be essential for MyD88-dependent pathway that relays the majority of innate immune responses [16] .
Limited information is available about the factors, including host immune mechanisms that induce Mtb growth and persistence, especially in HIV+LTBI+ individuals. To develop new tools to prevent tuberculosis in HIV+ individuals, it is important to identify the factors that regulate macrophage responses during Mtb infection in HIV+ individuals. In the current study, we determined TLR2, MyD88, IRAK4 and NF-kB expressions and cytokine production by CD14+ monocytes from PBMCs of HIV−LTBI+, HIV+LTBI+ individuals, HIV+TB+, HIV−TB+ patients and pleural fluids of TB patients with and without HIV infection. Pleural fluids were obtained via thoracentesis from 16 HIV−TB+ patients and 16 HIV+TB+ patients with tuberculous pleuritis with no history of anti-tuberculosis therapy. All patients had unilateral exudative effusions. The diagnosis was confirmed for all patients by culture of M. tuberculosis from pleural fluid or tissue and by histologic demonstration of granulomatous pleuritis in combination with a response to anti-tuberculosis therapy.
Materials and methods

Patient population
Antibodies and other reagents
For flow cytometry, we used FITC anti-CD14 (BD Biosciences), and PE anti-TLR2 (R&D systems) and PE anti-IgG isotype control antibody (BD Biosciences) . We used γ-irradiated Mtb H37Rv (BEI Resources) and TLR2 agonist Pam3CSK4 (synthetic triacylated lipoprotein, Invivogen) for in vitro stimulation assays.
Determination of latent tuberculosis in the study subjects
QuantiFERON-TB gold test was used to identify subjects having a latent TB infection (LTBI). The assay was performed according to manufacturer's instructions. Briefly, one ml of whole blood was added to each of the three QFT-TB tubes; TB antigen (ESAT-6, CFP-10 and TB 7.7), mitogen positive control (PHA) and a negative control. The tubes were treated as recommended by the manufacturer (Cellestis Ltd., Victoria, Australia) and IFN-γ concentration (IU/mL) in plasma was measured by an ELISA reader and LTBI status was calculated by the 'QFT-TB-analysis Software'
Isolation of CD14+ monocytes
PBMCs and PFMCs were isolated by differential centrifugation over Ficoll-Paque (Sigma Aldrich). CD14+ monocytes were isolated with magnetic beads conjugated to anti-CD14 (Miltenyi Biotec). The positively selected cells were > 95% CD14+ as measured by flow cytometry.
Culture of monocytes with γ-irradiated Mtb H37Rv
Freshly isolated CD14+ cells were cultured in 12-well plates at 2 × 10 6 cells/well in RPMI 1640 containing 1% penicillin/streptomycin (Sigma), L-Glutamine and 10% heat-inactivated human serum, with or without γ-irradiated Mtb H37Rv or TLR2 agonist at 37°C in a humidified 5% CO 2 atmosphere. After 48 h, cell-free culture supernatants were collected, aliquoted and stored at −70°C until cytokine concentrations were measured. For other experiments, RNA was extracted to perform real time PCR analysis to measure expression of MyD88, IRAK4 and NF-kB genes.
Real-time PCR for quantification of MyD88, IRAK4 and NF-kB mRNA
Total RNA was extracted from cultured cells, using TRIzol reagent (Invitrogen) and reverse transcribed, using iScript cDNA synthesis kit (Bio-Rad USA). The primers sequences were: Myd88 Forward: 5′TGCC CTGAAGACTGTTCTGA3′ Reverse 3′ACTGGTTCCATGCAGGACAT5′, IRAK-4 Forward 5′TGATGGAGATGACCTCTGCT 3′, Reverse 3′GGTGG AGTACCATCCAAGCA5′and NF-kB1p65 Forward 5′ ATCCCATCTTTGA CAATCGTGC Reverse 3′ CTGGTCCCGTGAAATACACCTC. Real-time PCR was performed using EVA Green (Bio-Rad, USA) on a spectrofluorometric thermal cycler (Mini Opticon, Bio-Rad). PCR was performed in duplicates as follows: 95°C for 10 min, and 45 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. All samples were normalized to the amount of GAPDH transcript present in each sample.
Measurement of IL-1β, TNFα, and IL-10 concentrations
Supernatants from γ-irradiated M. tuberculosis H37Rv-stimulated CD14 cells were collected after 48 h and stored at −70°C, until concentrations were measured by ELISA (eBiosciences) following manufacturer's instructions.
Measurement of MCP-1 and IP-10 in cell culture supernatants and pleural fluids
Cytometric Bead Array (CBA): Human CBA kit (BD Biosciences, San Diego, CA) was used to quantify the levels of chemokines (MCP-1 and IP-10) following manufacturer's instructions. Briefly, 50 µl of standard or sample was mixed with the 50 µl of premixed capture beads for respective chemokine and 50 µl of PE-labeled secondary detection reagent. After 3hrs of incubation at 4°C, excess detection reagent was removed by washing. Samples were acquired on FACS calibur with cellquest pro software. The concentrations of samples were calculated using CBA software (BD Biosciences, San Diego, CA).
Statistical analysis
Results are shown as mean ± SE. For data that were normally distributed, comparisons between groups were performed by a paired or unpaired t test, as appropriate. For data that were not normally distributed, the non-parametric Mann-U-Whitney test was performed.
Results
TLR2 expression by peripheral blood CD14+ monocytes
TLR2 expression on CD14 low and CD14 hi monocytes was determined by flow cytometry (Fig. 1 ) TLR2 expression on CD14 low cells was higher in HIV+LTBI+ patients than in HIV−LTBI+ healthy individuals ( Fig. 2A , p = 0.0001) and HIV+TB+ patients ( Fig. 2A , p < 0.0001).
The percentages these cells were higher in HIV−TB+ patients than in HIV+TB+ patients ( Fig. 2A , p = 0.01). Similarly, TLR2 agonist Pam3CSK4 (synthetic triacylated lipoprotein) also significantly increased MyD88 (Fig. 3B , p < 0.0001) and IRAK4 (Fig. 3B, 
Cytokine production by peripheral blood CD14+monocytes upon stimulation
CD14+ cells from HIV−LTBI+ individuals produced significantly higher amounts of IL-1β (Fig. 4A , p = 0.009), lower amounts of TNF-α (Fig. 4B , p = 0.02) and IL-10 ( Fig. 4C , p = 0.005) compared to HIV +LTBI+ individuals. Whereas HIV+TB+ patients produced significantly lower amounts of IL-1β (Fig. 4A , p = 0.004), and TNF-α (Fig. 4B , p = 0.002), and higher amounts of IL-10 (Fig. 4C , p = 0.02), compared to HIV−TB+ patients.
We also stimulated CD14+ cells of HIV−LTBI+ healthy individuals and HIV+LTBI+ patients with TLR2 agonist Pam3CSK4 (synthetic triacylated lipoprotein). Similar increase in IL-1β (Fig. 4D , p < 0.0001), decrease in TNF-α (Fig. 4E , p = 0.0006), and IL-10 ( Fig. 4F , p = 0.0001) production was noted in HIV−LTBI+ healthy individuals compared to HIV+LTBI+ individuals.
Chemokine production by peripheral blood CD14+monocytes upon stimulation
In the above culture supernatants, we also measured MCP-1 and IP-10 levels and found that CD14+ cells from HIV−LTBI+ individuals produce significantly higher amounts of MCP-1 (Fig. 5A , p = 0.002), and IP-10 (Fig. 5B , p = 0.003) compared to HIV+LTBI+ individuals.
Our above results demonstrate that increased TLR2 expression by freshly isolated CD14+ cells of HIV+LTBI+ individuals do not correlate with the expression of MyD88 and IRAK4 and cytokine production upon γ-irradiated Mtb H37Rv or TLR2 agonist stimulation.
Cytokine and chemokine levels at the site of disease (pleural fluids) and cell cultures
Pleural fluids from HIV+TB+ patients had low, IL-1β ( 
MyD88 and IRAK4 expression by CD14+cells in pleural fluid upon stimulation
We next determined whether cytokine and chemokine levels in pleural fluids of HIV+ and HIV− active tuberculosis patients correlate with the MyD88, IRAK4, NF-kB expressions by pleural fluid CD14+ cells upon γ-irradiated Mtb stimulation. CD14+ cells were isolated from pleural fluid by magnetic selection as mentioned in methods section and cultured with γ-irradiated Mtb. After 48 h expressions of MyD88, IRAK4 and NF-kB were determined by real-time PCR. γ-irradiated Mtb cultured pleural fluid CD14+ cells of HIV+TB+ patients expressed significantly less MyD88 (Fig. 7 , p = 0.003) and IRAK4 (Fig. 7) and similar NF-kB expression compared to HIV−TB+ patients. 
Discussion
Monocytes/macrophages offer first line of defense arresting bacterial replication and containing the latent Mtb infection [17] . They are a heterogeneous population and consist of CD14 low and CD14 hi subsets, most predominant of them, are "classical monocytes", expressing high levels of CD14 on their surface. The more abundant "nonclassical monocytes", are characterized by very low expression of surface CD14. These subsets are either inflammatory or phagocytic [18] [19] [20] [21] . HIV infection dampens the body's natural ability to fight infections and increases the likelihood of activation of latent tuberculosis infection [22, 23] . There is a limited information available about the factors that regulate monocyte/macrophage defenses against Mtb infection in HIV infected individuals [24] [25] [26] . TLR-2 expressed by antigen presenting cells is known to play an important role in production of cytokines and chemokines to induce antimicrobial defense mechanism/s [27, 28] . There is no information available about expression of TLR-2 and signaling molecules (MyD88, IRAK4 and NF-kB) those are involved in TLR-2 mediated cytokines and chemokines production in HIV+ individuals with LTBI or active TB disease. In the current study, we found increased TLR2 expression on CD14 low and CD14 hi cells in the periph- active TB disease. Surprisingly we found that there was no significant difference in NF-kB expression in any of our groups indicating that the regulation of the cytokine and chemokine production happens at MyD88 and IRAK4 rather than at NF-kB. TLR2 knockout mice had defective tuberculosis granuloma formation and were susceptible to Mtb infection [29, 30] . HIV infection upregulates TLR2 expression by monocytes for the production of TNF-α and IL-10 [31, 32] . Increased TLR2 expression in HIV+ active TB patients has been reported previously as a biomarker in HIV+TB+ IRIS (immune reconstitution inflammatory syndrome) [33] . Our results are in line with these findings and further demonstrate that HIV infection in LTBI+ individuals inhibits the expression of key molecules in TLR2 signaling pathway. Activation of TLR-2 pathway leads to anti-viral proinflammatory cytokine and chemokine production which are also essential to prevent Mtb replication. Our results also demonstrate that HIV infection prevents TLR-2 dependent proinflammatory cytokine and chemokine production in individuals with LTBI+. IRAK4 is critical for MyD88-dependent TLR signaling, and patients with IRAK-4 mutations are extremely susceptible to recurrent bacterial infections [34, 35] . Upon activation of the MyD88-dependent pathway, TLR2 associated MyD88 forms "Myddosome" complexes by recruiting IRAK4 [36, 37] . We found γ-irradiated Mtb H37Rv and TLR2 agonist significantly inhibit IL-1β, MCP-1 and IP-10 production by CD14+ cells of HIV+LTBI +, and HIV+ and HIV− active TB patients compared to HIV−LTBI+ healthy individuals. Our results suggest HIV infection inhibits the expression of IRAK4 and MyD88 to prevent "Myddosome" complex formation which is crucial for the production of pro-inflammatory cytokines and chemokines to contain both HIV and TB infection.
We found γ-irradiated Mtb H37Rv and TLR2 agonist significantly enhance TNF-α and IL-10 production by CD14+ cells of HIV+LTBI+, HIV+ and HIV− active TB patients compared to HIV−LTBI+ healthy individuals. Increased TNF-α production suggests immune activation for increased viral replication as found previously [38, 39] . IL-10 is known to inhibit production of reactive nitrogen intermediates, causes reduced macrophage function and reactivation of TB [40] [41] [42] . Enhanced IL-10 production by CD14+ cells of HIV+LTBI+, and HIV+ and HIV− active TB patients suggest disruption of immune responses, enhanced Mtb growth and progression of LTBI to ATB.
Chemokines have been associated with numerous key processes that lead to Mtb containment, from recruitment of myeloid cells into the lung to activation of adaptive immunity and formation of protective granulomas [43] [44] [45] . MCP-1 and IP-10 have been studied in the context of immune activation and viral replication in HIV [46] [47] [48] . In the current study, we found γ-irradiated Mtb H37Rv and TLR2 agonist stimulation of CD14+ of HIV+ LTBI+, and HIV+ and HIV− active TB patients produce less MCP-1 and IP-10 compared to HIV−LTBI+ healthy individuals. Our results suggest defective TLR-2 mediated signaling pathways leads to poor chemotaxis and recruitment of immune cells at the site of infection and defective control of Mtb growth in HIV + individuals with LTBI or active disease. We found higher levels of TNF-α and IL-10 in the pleural fluids and culture supernatants of HIV+ tuberculosis patients. HIV− tuberculosis patients have higher levels of IL-1β, MCP-1 and IP-10 in pleural fluids and culture supernatants. These findings are similar to those observed in CD14+ cells from peripheral blood suggesting their relevance and reiterating their importance at the site of disease.
In summary, we found HIV infection inhibits expression of molecules (MyD88 and IRAK4) involved in TLR-2 signaling pathway, regardless of TLR-2 expression in LTBI+ individuals. This leads to reduced production of cytokines and chemokines essential to control TB growth and progression of LTBI to TB in HIV+ individuals. 
Conclusions
Understanding the mechanisms how HIV infection inhibits the expression of molecules involved in TLR-2 mediated pathways will facilitate development of immunomodulatory strategies to boost innate immunity to Mtb and prevent progression of LTBI to TB in highly susceptible HIV−infected population.
